Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Cash from Operations (2016 - 2026)

Protara Therapeutics' Cash from Operations history spans 14 years, with the latest figure at 21343000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 45.06% to 21343000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 62995000.0 through Mar 2026, down 56.93% year-over-year, with the annual reading at 56365000.0 for FY2025, 57.41% down from the prior year.
  • Cash from Operations came in at 21343000.0 for Q1 2026, down from 16950000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5026000.0 in Q4 2022 to a low of 21343000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 9408000.0 (2023), against an average of 10442941.18.
  • Year-over-year, Cash from Operations skyrocketed 45.93% in 2022 and then plummeted 83.64% in 2023.
  • Protara Therapeutics' Cash from Operations stood at 5026000.0 in 2022, then plummeted by 73.1% to 8700000.0 in 2023, then fell by 6.99% to 9308000.0 in 2024, then plummeted by 82.1% to 16950000.0 in 2025, then dropped by 25.92% to 21343000.0 in 2026.
  • Per Business Quant, the three most recent readings for TARA's Cash from Operations are 21343000.0 (Q1 2026), 16950000.0 (Q4 2025), and 12452000.0 (Q3 2025).